Jagsonpal Pharmaceuticals Limited
Share Price Target & Analysis

NSE:JAGSNPHARM

231.32

VWAP

234

Open

236.04

Close

236.49

High

226.79

Low

288.5

52 Week High

230.80 ⇩
-5.24 (-2.22%)

JAGSNPHARM

(PHARMA)
56.8% Momentum

Turnaround Potential

155

52 Week Low

6.9

EPS

51.52

PE

5.51

PB

Economical
Quality

Gold
Valuation

#Analysis

NSE: JAGSNPHARM Share Price Financial Analysis & Valuation

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Micro Cap company with Market Capitalization of Rs 423.1 (in Cr). Total number of free float shares are 2.6 (in Lacs). Jagsonpal Pharmaceuticals Limited is listed on NSE with Exchange ID - INE048B01035 and trading code is NSE:JAGSNPHARM with short name JagsonpalPharma.

In the past 1 year, Jagsonpal Pharmaceuticals Limited has declared an equity dividend of Rs 4 per share. At the current share price of JAGSNPHARM at Rs 230.80, this results in a dividend yield of 1.73 %.

As per the Fundamental Analysis of NSE:JAGSNPHARM, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine JAGSNPHARM underlying value and future prospects. All of this data is available in JAGSNPHARM financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:JAGSNPHARM, it is clearly understood that JAGSNPHARM is Economical performer in terms of earnings and profit margins with an EPS of 6.9. NSE:JAGSNPHARM book value per share as of today is 41.86. The current price to book ratio for JAGSNPHARM as of Aug 01, 2026 is 5.51.

Valuation of the Stock: The current valuation of JAGSNPHARM stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of JAGSNPHARM whether to BUY this stock at current valuation. The delivery percentage of JAGSNPHARM is 4.95% is very crucial parameter which shows that 4.95% investors are anticipating that the price of JAGSNPHARM share should go up with VWAP at 231.32.

Now, the main question is whether to BUY or SELL, NSE:JAGSNPHARM at current valuation.
As per latest Analysis No. #1327:-

⇑ STRONG BUY JAGSNPHARM if All Greens

⇗ BUY JAGSNPHARM (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD JAGSNPHARM (With Stop Loss) if only 1 Green

⇘ SELL JAGSNPHARM if NO Green Indicator

NSE: JAGSNPHARM Share Price Today (Aug 01, 2026)

(Jagsonpal Pharmaceuticals Limited Daily Analysis on the basis of JAGSNPHARM Intraday Graph & Trend)

Jagsonpal Pharmaceuticals Limited share price moved Down by -2.22% from its previous close of Rs 236.04. JAGSNPHARM stock last traded price is 230.80. JAGSNPHARM share price trend is Down with a total of 451990 stocks traded till now. It has touched an intraday high of Rs 236.49 and an intraday low of Rs 226.79. The JAGSNPHARM trading at 230.80, Down by Rs. -5.24, or -2.22 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Down.

NSE: JAGSNPHARM Share Price Tomorrow Prediction

(Jagsonpal Pharmaceuticals Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of JAGSNPHARM)

Jagsonpal Pharmaceuticals Limited share price moved Down by -2.22%. JAGSNPHARM share price short term trend is Down. It suggests that JAGSNPHARM Share Price for Tomorrow remains the same with VWAP at 231.32 will be treated as stop loss for intraday traders. Jagsonpal Pharmaceuticals Limited Long term investors can follow the JAGSNPHARM long term trend as mentiond in future forecast table.

NSE Code

NSE: JAGSNPHARM

JAGSNPHARM Share Price Today

 230.80

JAGSNPHARM Share Price Target Prediction for 2026 ^

 213.3 - 289.9

JAGSNPHARM Share Price Target Prediction for 2027*^

 289.9 - 308.9

JAGSNPHARM Share Price Target Prediction for 2028*^

 308.9 - 330.5

JAGSNPHARM Share Price Target Prediction for 2029*^

 347

JAGSNPHARM Share Price Target Prediction for 2030*^

 357

JAGSNPHARM Share Price Target Prediction for 2035*^

 389
JAGSNPHARM Current Book Value 2025
41.7

*Jagsonpal Pharmaceuticals Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^JAGSNPHARM share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

JAGSNPHARM Technical Analysis

Candlestick Pattern: @232.77

JAGSNPHARM Moving Averages

BUY (11) NEUTRAL (0) SELL (3)
MA Simple Action S1 Expo Action E2
MA_5 233.81 SELL 233.06 SELL
MA_12 233.26 SELL 230.47 BUY
MA_20 226.04 BUY 226.82 BUY
MA_32 217.25 BUY 220.81 BUY
MA_50 214.44 BUY 215.65 BUY
MA_100 201.92 BUY 208.42 BUY
MA_200 201.02 BUY 205.78 BUY

JAGSNPHARM Trend Oscillators

BUY (3) NEUTRAL (0) SELL (1)
Trend Oscillators Value Action
Bollinger Bands 226.04 Uptrend
MACD -0.27 SELL
ADX 34.53 Strong Trend
DMI (+/-) 23.37 / 11.17 Uptrend

JAGSNPHARM Momentum Oscillators

BUY (1) NEUTRAL (9) SELL (2)
Momentum Oscillators Value Action
RSI 60.02 Neutral
STOCHASTIC_K (Fast) 28.35 Neutral
STOCHASTIC_D (Slow) 22.44 Neutral
CCI 11.57 Neutral
PSAR 257.79 SELL
TRUE RANGE 8.9 Neutral
ATR 11.13 Neutral
WILLIAMS R -60.76 Neutral
TRIX 0 Neutral
STOCHASTIC RSI K 25.32 Neutral
STOCHASTIC RSI D 15.05 Oversold
MOMENTUM 28.24 BUY

JAGSNPHARM Last 1 Year Trend

Duration Value
1 Year 1.29%
3 Months 22.14%
1 Month 13.81%
1 Week -1.63%

JAGSNPHARM Technical Analysis Summary

Updated on 2026-07-10
Action Overall (%)
BUY 50%
NEUTRAL / HOLD 30%
SELL 20%

Most popular Questions & Answers about JAGSNPHARM


Jagsonpal Pharmaceuticals Limited stock last traded price is 230.80. JAGSNPHARM share price moved Down by -2.22% from its previous close of Rs 236.04.

Jagsonpal Pharmaceuticals Limited share price trend is Down with a total of 451990 stocks traded till now. It has touched an intraday high of Rs 291.385 and an intraday low of Rs 226.79. The JAGSNPHARM trading at 230.80, Down by Rs. -5.24, or -2.22 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Down and the Stop Loss will be around 231.32.

The market cap of Jagsonpal Pharmaceuticals Limited is ₹423.1 (in Cr) as of Jul 31, 2026.

The current price to earning ratio for Jagsonpal Pharmaceuticals Limited as of Jul 31, 2026 is 51.52.

The current price to book ratio for Jagsonpal Pharmaceuticals Limited as of Jul 31, 2026 is 5.51.

The highest price of Jagsonpal Pharmaceuticals Limited stock is ₹288.5 in the last 52-week.

The lowest price of Jagsonpal Pharmaceuticals Limited stock is ₹155 in the last 52-week.

Jagsonpal Pharmaceuticals Limited share trading at ₹230.80, Down by Rs. -5.24, or -2.22 percent which suggests that most of the traders are anticipating that the price of JAGSNPHARM share should go Down.

In 2025, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹213.3 on downside and ₹289.9 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on current financial year earings of the company.

In 2026, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹289.9 on downside and ₹308.9 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on forecasted future earnings of the company.

In 2027, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹308.9 on downside and ₹330.5 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) will be around ₹357 Jagsonpal Pharmaceuticals Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of JAGSNPHARM.

The price of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) shares moved by -2.22%. The short-term trend for JAGSNPHARM share price is Down. It implies that the share price of JAGSNPHARM will stay the same tomorrow and that intraday traders should treat VWAP at 231.32 as a stop loss. Investors with a long-term outlook can track JAGSNPHARM long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of JAGSNPHARM stock is 82.7. Compared to the current market price of 230.80 INR, the JAGSNPHARM stock is Overvalued by 64.2%.

As per the fundamental analysis of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM), it is of Economical quality in terms of earnings and profit margins with an EPS of 6.9. Jagsonpal Pharmaceuticals Limited book value per share as of today is 41.86. The current price to book ratio for JAGSNPHARM as of Aug 01, 2026 is 5.51.


NSE:JAGSNPHARM News & Other Useful Information about JAGSNPHARM Share Price


Peer Comparison of NSE: JAGSNPHARM

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1990.50 10.97 93.24
DIVISLAB 8056.00 98.2 629.49
MEDICAMEQ 234.55 6.94 206.22
CIPLA 1473.20 38.05 423.36
DRREDDY 1148.10 7.95 375.78
PGHH 5215.00 189.8 373.34
TORNTPHARM 5122.80 57.63 222.76
BIOCON 425.70 0.23 166.19
LUPIN 2415.00 139.24 659.04
ALKEM 5751.50 190.87 1170.81
Updated at: 31 Jul 2026 15:59

Feel free to contact us, in case of any queries.

SITEMAP 2237
Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 3009.50 -39.60 (-1.3%) | ADANIGREEN 1383.00 24.30 (1.79%) | ADANIPORTS 1696.50 32.40 (1.95%) | ADANITRANS 988.50 0.35 (0.04%) | AMBUJACEM 432.20 -2.00 (-0.46%) | APOLLOHOSP 8957.00 -31.00 (-0.34%) | ASIANPAINT 2747.30 1.10 (0.04%) | ATGL 651.45 1.30 (0.2%) | AUROPHARMA 1580.20 3.90 (0.25%) | AXISBANK 1229.50 0.60 (0.05%) | BAJAJ-AUTO 11520.50 88.50 (0.77%) | BAJAJFINSV 2029.10 119.70 (6.27%) | BAJFINANCE 1141.20 87.70 (8.32%) | BALKRISIND 2473.50 166.60 (7.22%) | BANDHANBNK 174.13 1.41 (0.82%) | BANKBARODA 242.60 0.95 (0.39%) | BEL 387.85 2.95 (0.77%) | BERGEPAINT 520.45 -0.90 (-0.17%) | BHARTIARTL 1972.00 15.20 (0.78%) | BIOCON 425.70 0.35 (0.08%) | BOSCHLTD 41085.00 -465.00 (-1.12%) | BPCL 319.75 3.95 (1.25%) | BRITANNIA 5416.50 -108.00 (-1.95%) | CADILAHC 905.25 2.35 (0.26%) | CIPLA 1473.20 6.80 (0.46%) | COALINDIA 414.15 -3.05 (-0.73%) | COLPAL 2076.10 -8.70 (-0.42%) | DABUR 421.45 -4.65 (-1.09%) | DIVISLAB 8056.00 221.00 (2.82%) | DLF 659.30 4.45 (0.68%) | DMART 3921.00 47.00 (1.21%) | DRREDDY 1148.10 3.30 (0.29%) | EICHERMOT 7833.50 -79.00 (-1%) | GAIL 181.44 7.80 (4.49%) | GLAND 2502.90 -14.10 (-0.56%) | GODREJCP 1070.40 -1.70 (-0.16%) | GRASIM 3100.80 -4.00 (-0.13%) | GUJGASLTD 327.05 -8.25 (-2.46%) | HAVELLS 1260.70 -1.00 (-0.08%) | HCLTECH 1346.90 -5.80 (-0.43%) | HDFC 2724.30 0.00 (0%) | HDFCAMC 2615.80 69.50 (2.73%) | HDFCBANK 748.15 -5.80 (-0.77%) | HDFCLIFE 548.50 3.10 (0.57%) | HEROMOTOCO 5386.00 61.00 (1.15%) | HINDALCO 974.45 4.05 (0.42%) | HINDUNILVR 2101.30 -6.60 (-0.31%) | HINDZINC 539.20 3.30 (0.62%) | ICICIBANK 1435.40 1.50 (0.1%) | ICICIGI 1623.70 -14.20 (-0.87%) | ICICIPRULI 515.40 4.80 (0.94%) | INDIGO 5171.00 -59.50 (-1.14%) | INDUSINDBK 1012.45 1.00 (0.1%) | INDUSTOWER 391.10 -1.80 (-0.46%) | INFY 1130.10 -25.00 (-2.16%) | IOB 33.90 0.17 (0.5%) | IOC 140.17 0.23 (0.16%) | ITC 281.00 -4.05 (-1.42%) | JSWSTEEL 1270.00 -0.80 (-0.06%) | KOTAKBANK 390.30 0.90 (0.23%) | LT 3938.90 1.20 (0.03%) | LTI 5706.50 -337.50 (-5.58%) | LUPIN 2415.00 -6.20 (-0.26%) | M&M 3398.50 114.80 (3.5%) | MARICO 870.65 -14.70 (-1.66%) | MARUTI 14234.00 46.00 (0.32%) | MCDOWELL-N 1358.10 -8.00 (-0.59%) | MOTHERSUMI 121.00 -1.62 (-1.32%) | MUTHOOTFIN 3119.60 110.90 (3.69%) | NAUKRI 1226.25 -17.80 (-1.43%) | NESTLEIND 1509.60 -11.10 (-0.73%) | NMDC 85.04 0.03 (0.04%) | NTPC 347.25 2.40 (0.7%) | ONGC 242.53 0.94 (0.39%) | PEL 1124.20 0.00 (0%) | PIDILITIND 1611.40 -18.50 (-1.14%) | PIIND 2751.20 -26.10 (-0.94%) | PNB 112.71 1.07 (0.96%) | POWERGRID 284.25 -1.45 (-0.51%) | RELIANCE 1307.80 14.90 (1.15%) | SAIL 169.03 -0.02 (-0.01%) | SBICARD 660.15 2.35 (0.36%) | SBILIFE 1882.00 4.50 (0.24%) | SBIN 1027.40 2.10 (0.2%) | SHREECEM 26055.00 -400.00 (-1.51%) | SIEMENS 3760.00 101.20 (2.77%) | SRF 2622.50 17.70 (0.68%) | SUNPHARMA 1990.50 -10.60 (-0.53%) | TATACONSUM 1083.10 -11.10 (-1.01%) | TATAMOTORS 375.45 3.40 (0.91%) | TATAMTRDVR 768.65 33.35 (4.54%) | TATASTEEL 189.69 2.77 (1.48%) | TCS 2365.60 -66.20 (-2.72%) | TECHM 1651.30 -17.70 (-1.06%) | TITAN 4875.20 25.20 (0.52%) | TORNTPHARM 5122.80 250.70 (5.15%) | ULTRACEMCO 11903.00 56.00 (0.47%) | UPL 604.30 1.75 (0.29%) | VEDL 264.25 -3.25 (-1.21%) | WIPRO 183.65 -2.68 (-1.44%) |